Cargando…
MicroRNAs as a clue to overcome breast cancer treatment resistance
Breast cancer is the most frequent cancer in women worldwide. Despite the improvement in diagnosis and treatments, the rates of cancer relapse and resistance to therapies remain higher than desirable. Alterations in microRNAs have been linked to changes in critical processes related to cancer develo...
Autores principales: | Garrido-Cano, Iris, Pattanayak, Birlipta, Adam-Artigues, Anna, Lameirinhas, Ana, Torres-Ruiz, Sandra, Tormo, Eduardo, Cervera, Raimundo, Eroles, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924146/ https://www.ncbi.nlm.nih.gov/pubmed/34524579 http://dx.doi.org/10.1007/s10555-021-09992-0 |
Ejemplares similares
-
MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma
por: Pattanayak, Birlipta, et al.
Publicado: (2020) -
Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway
por: Pattanayak, Birlipta, et al.
Publicado: (2022) -
Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer
por: Adam-Artigues, Anna, et al.
Publicado: (2021) -
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
por: Torres-Ruiz, Sandra, et al.
Publicado: (2023) -
Delivery
of miR-200c-3p
Using Tumor-Targeted Mesoporous
Silica Nanoparticles for Breast Cancer Therapy
por: Garrido-Cano, Iris, et al.
Publicado: (2023)